Pharmaceutical Industry Reports Non-Small Cell Lung Cancer Market | Page 4

REPORT DESCRIPTION
Non-Small Cell Lung Cancer Market – Key Players
AstraZeneca Plc
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Agennix AG
ArQule Inc
GlaxoSmithKline Pharmaceuticals Limited
Daiichi Sankyo Co. Ltd
Sanofi-Aventis
Boehringer Ingelheim GmbH. Also as per U.S. Food and Drug Administration some latest drug approvals
in Market of non-small cell lung cancer by USFDA are on October 24, 2016 pembrolizumab (Merck &
Co., Inc.) received approval, also FDA approved atezolizumab for the treatment of NSCLC on October 18,
2016.
Get More Inf @
https://www.coherentmarketinsights.com/ongoing-insight/non-small-cell-lung-cancer-market-241